Polish Registry of Takotsubo Syndrome

NCT04634487 · tracked via the Priya Life Science Poland tracker

Sponsor

Medical University of Warsaw

Phase

Observational

Started

2020-10-01

Last updated

2020-11-18

Condition(s) studied

Takotsubo Syndrome

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

Polish registry of takotsubo syndrome

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: all patients with takotsubo syndrome Exclusion Criteria: \-

Primary outcome measure(s)

Number of participants with in-hospital complications and mortality — through study completion, an average of 1 year
In hospital complications include atrial fibrillation, ventricular tachycardia, ventricular fibrillation, atrioventricular block, cardiogenic shock, cardiac arrest

Trial sites (1)

Facility	City	Region	Status
Medical University of Warsaw	Warsaw	Poland	Recruiting

More Medical University of Warsaw trials in Poland

Bedside Ultrasound on the Effectiveness of Lumbar Puncture in Children. Recruiting

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients Recruiting

Early vs Late Urinary Catheter Removal After Renal Transplantation Active, not recruiting

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) Active, not recruiting

Multimodality Imaging and Functional Lesion Assessment in Intermediate Coronary Stenosis in Chronic Coronary Syndrome Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04634487 on ClinicalTrials.gov ↗ ← All trials in Poland